It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

This page is not supported in mobiles. Please view it in the desktop version.

BioPharma Solutions BioPharma Solutions
Sterile Contract Manufacturing

Antibody-Drug Conjugates

Print
Antibody Drug Conjugates

Baxter’s BioPharma Solutions business (BPS) and SAFC (a business unit of Sigma Aldrich), two of the leading contract manufacturing organizations (CMOs) in the antibody-drug conjugate (ADC) space, are now offering a combined approach for your ADC to simplify the supply chain and provide comprehensive, coordinated and collaborative services for the development, manufacturing, and testing of bulk drug substance (BDS) and drug product (DP).

SAFC and BPS have hands-on experience with more than 20 different ADC constructs. Both companies have dedicated facilities that are SafeBridge Certified to handle Category 4 compounds. Together we offer the complete range of services needed for ADCs:

  • Formulation Development
  • Analytical Development
  • Process Development
  • Linkers/Cytotoxic Agents
  • Conjugation
  • Fill/Finish

For more information on the BioPharma Solutions/SAFC collaboration, read our announcement

For additional information regarding our ADC services and benefits, download our ADC fact sheet.

For more information on SAFC and their ADC capabilities, visit their website.

Need a CMO for your ADC project? Contact us today.

Events Events
Events

Events

Talk to us at these events